- Country: Slovakia
- Summary: Dinutuximab 4.5 Mg/1 Ml, Concentrate on the Infusion Solution Description: the Subject of the Order is a Drug with an Arranged Dinutuximab in a Concentration of 4.5 Mg/1Ml; Concentrate on Infusion Solution, Supplement: Con Infin 4.5 Ml/20 M ...
- SKT Ref No: 117664822
- Deadline: 19 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 902994.5
- Notice Type: Tender
- Document Ref. No.: 6645 - MST
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Dinutuximab 4.5 mg/1 ml, concentrate on the infusion solution Description: The subject of the order is a drug with an arranged dinutuximab in a concentration of 4.5 mg/1ml; Concentrate on infusion solution, supplement: con infin 4.5 ml/20 mg (drug. Inj. Skl).Since the 12 months, which was filed before the administration of chemotherapy and achieved at least a partial response, followed by myeloablative treatment and transplantation of stem cells, as well as in patients with historia of related or refractive neuroblastom with or without residual disease. The treatmentWith this medicine, it consists of 5 cycles of Intuchi in a row, and every cycle lasts 35 days. The individual dose is determined according to the body area and a total of 100 mg/m2 per cycle. Type of Candy: Goods 4.1.4 RangeProcurement The estimated value assumed value (BT-27-Procedure) (value): 902 994.5 Anticipated value (BT-27-Procedure) (currency): Euro maximum value of Ramc Agreement Maximal value of Ramco Agreement (BT-271-Procedure)(BT-271-Procedure) (currency): Euro information on the main classification of the subject of the Candard Type of Classification: Common Dictionary of Procurement of Main CPV COD: antineoplastic and immunomodulatory agent of information on additional classificationClassification: Common dictionary of procurement 4.1.5 Information on the point of information on the point of information on the place of fulfillment Street: L. Svoboda 4 City: Banska Bystrica Postcode: 97409 Nizsia Evening Unit of the country: Banska Bystrica County Country: Slovakia 4.2 SUMBERS CONDITIONS 4.2.1.Elimination of the reason for exclusion: corruption of the description/way of proving: the seer or the enthusiasm proves the fulfillment of the condition of the participation according to § 32 par. 1 pism. a) of the Act on Public Obstimion no. 343/2015 Coll. one of theComes ...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDinutuximab 4.5 Mg/1 Ml, Concentrate on the Infusion Solution Description: the Subject of the Order is a Drug with an Arranged Dinutuximab in a Concentration of 4.5 Mg/1Ml; Concentrate on Infusion Solution, Supplement: Con Infin 4.5 Ml/20 M ... - Slovakia Tender
The CHILDREN'S FACULTY HOSPITAL WITH POLYCLINIC BANSKA BYSTRICA, a Government sector organization in Slovakia, has announced a new tender for Dinutuximab 4.5 Mg/1 Ml, Concentrate on the Infusion Solution Description: the Subject of the Order is a Drug with an Arranged Dinutuximab in a Concentration of 4.5 Mg/1Ml; Concentrate on Infusion Solution, Supplement: Con Infin 4.5 Ml/20 M .... This tender is published on SlovakiaTenders under SKT Ref No: 117664822 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-19.
The estimated tender value is EUR 902994.5, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
